Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Poniard Pharmaceuticals Inc
PARDCurrent price
0.0001 USD
0 USD (0.00%)
Last closed
0.0001 USD
Company
–
ISIN
US7324494001
Sector
Healthcare
Industry
Biotechnology
Exchange
PINK
Capitalization
299 845 USD
Yield for 12 month
-99.00 %
1Y
3Y
5Y
10Y
15Y
PARD
Poniard Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of cancer therapeutics. Its lead platform product candidate includes Picoplatin, a platinum-based cancer therapy to treat multiple cancer indications, including small cell lung, colorectal, prostate, and ovarian cancers. The company has conducted a pivotal Phase III SPEAR trial of Picoplatin in the second-line treatment of patients with small cell lung cancer; Phase II trials evaluating picoplatin as a first-line treatment of metastatic colorectal cancer and castration-resistant prostate cancer; and a Phase I study evaluating an oral formulation of picoplatin in solid tumors. The company was formerly known as NeoRx Corporation and changed its name to Poniard Pharmaceuticals, Inc. in September 2006. Poniard Pharmaceuticals, Inc. was founded in 1984 and is based in Seattle, Washington. Address: 300 Elliott Avenue West, Seattle, WA, United States, 98119
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
1 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Key Figures PARD
1 year
3 years
5 years
10 years
EBITDA
-13 041 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-46.03 %
PEG Ratio
–
Return On Equity TTM
-210.37 %
Wall Street Target Price
1 USD
Revenue TTM
–
Book Value
2.08 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-0.01 USD
Diluted Eps TTM
-0.01 USD
Most Recent Quarter
III 2011
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics PARD
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History PARD
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:40
Payout Ratio
–
Last Split Date
23.11.2011
Dividend Date
–
Stock Valuation PARD
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-0.0305
Price Book MRQ
0.0963
Financials PARD
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators PARD
For 52 weeks
0.0001 USD
0.01 USD
50 Day MA
0.0001 USD
Shares Short Prior Month
3 735
200 Day MA
0.0022 USD
Short Ratio
2.56
Shares Short
47 723
Short Percent
4.11 %
BeatStart